A Return to Use During IOP: What to Discuss With the Treatment Team

A return to substance use during IOP can trigger shame, fear, and quick conclusions. A person may hide what happened because they expect to be discharged. Family members may assume the entire treatment effort was wasted. Neither response helps the treatment team evaluate current risk.

For someone in a San Diego outpatient program, the most useful next step is prompt, accurate communication. A return to use is important clinical information. It may show that a trigger plan needs revision, mental health symptoms have changed, medication should be discussed, outside support is not enough, or the current level of care needs reassessment.

Start With Immediate Safety

Before reviewing why the use occurred, address what is happening now. Call 911 for unresponsiveness, slow or stopped breathing, blue or gray lips, seizure-like activity, severe confusion, chest pain, suicidal intent, serious violence, or another immediate emergency. If opioid exposure is possible, administer naloxone if available and call emergency services according to its instructions.

Do not assume the substance is known because of how it looked or was described. Illicit drugs may contain unexpected substances. Tell emergency responders and the treatment team what is known and what is uncertain.

If there is no immediate emergency, the person should still contact the program promptly. Avoid driving while impaired. Arrange safe transportation if an in-person assessment is recommended.

Report the Details Without Editing the Story

The treatment team needs specific information: what was used, when, how much if known, how it was taken, where it came from, and whether alcohol, prescriptions, or other drugs were involved. Include current symptoms, sleep, food, hydration, medications, and whether the person was alone.

Also describe the hours before use. Was there an argument, payday, missed medication, pain flare, insomnia, work stress, loneliness, contact with an old friend, or a skipped IOP session? The goal is not to build an excuse. It is to find the sequence that the next plan must address.

Do not wait for a scheduled group several days away if there are current safety concerns. Ask the program whom to contact after hours and when urgent medical evaluation is appropriate.

Treat the Event as a Plan Review

NIDA explains that a return to drug use can signal a need to resume, modify, or add treatment. It does not automatically mean that treatment has failed. Substance use disorders often require continuing evaluation, and progress is not measured by pretending difficult events did not happen.

The review may cover session frequency, individual counseling, group fit, medication, toxicology testing, transportation, peer support, family involvement, housing, work, and co-occurring mental health symptoms. If anxiety, depression, trauma symptoms, mania, psychosis, or suicidal thoughts are present, they should be discussed directly as part of dual diagnosis planning.

SAMHSA's IOP guidance describes intensive outpatient treatment as structured care delivered while a person lives outside a residential setting. That makes the recovery environment important. A plan that works during program hours may still need stronger support at night, on weekends, or around a high-risk location.

Consider Overdose Risk After Reduced Use

If opioids are involved, tolerance may be lower after a period of abstinence or reduced use. CDC guidance identifies return to a previously used high dose after lost tolerance as an overdose risk. The person should not assume that an amount used before treatment is safe now.

Ask the treatment team about naloxone, overdose education, and evidence-based medication for opioid use disorder. Do not stop or restart prescribed medication without professional guidance. If the drug came from an unregulated source, uncertainty about fentanyl or other contaminants increases the need for caution.

Overdose planning is useful even when the person believes the event will not happen again. It is a practical safety step, not an accusation.

Decide Whether IOP Is Still the Right Fit

A return to use does not answer the level-of-care question by itself. The team will consider the substance, pattern, medical risk, mental health symptoms, home environment, attendance, motivation, and ability to stay safe between sessions.

Some people may continue IOP with a revised plan. Others may need more structure through PHP, withdrawal management, residential care, emergency evaluation, or another recommendation. Amity San Diego is an outpatient provider, so any need for detox or residential care should be handled as a referral or step in the broader continuum, not as a service the outpatient program claims to provide.

Ask what would indicate that outpatient care is no longer sufficient. Repeated intoxication during sessions, escalating use, inability to attend, unstable psychiatric symptoms, unsafe housing, or serious medical concerns may change the recommendation.

Involve Family Without Creating an Interrogation

Family members can help by encouraging honesty, providing safe transportation, keeping naloxone available when relevant, reducing access to substances in the home, and following an agreed emergency plan. They should avoid searching for a confession, demanding every therapy detail, or treating the person as permanently untrustworthy.

A calm question such as "What does the team need to know today?" is more useful than "How could you do this after everything we have done?" Boundaries still matter. Families do not have to allow intoxicated driving, threats, violence, or substance use in the home.

If family involvement would help, ask how consent and communication work. The person in treatment should understand what may be shared and who is part of the plan.

Prepare the Next Seven Days

Turn the review into a short, concrete schedule. Include the next clinical contact, IOP sessions, transportation, meals, sleep, medication instructions, support calls, and high-risk times. Remove avoidable access to the substance and plan what the person will do if the trigger returns, including any relapse prevention steps the team recommends.

Review admissions and insurance information if the level of care may change. Benefits and authorization can affect timing, but insurance should not be treated as a clinical decision-maker.

The most important message is that honesty creates options. Hiding a return to use protects the old plan even when it no longer fits. Sharing it gives the treatment team a chance to respond to the person who is present today.

This article is for educational purposes only and is not medical advice, diagnosis, or treatment. If you or someone else may be in immediate danger, call 911 or seek emergency care.